Interim study to examine the governance and operational structure of Nebraska's prescription drug monitoring program, including its relationship with the health information exchange

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 3 Sponsors

No sponsors recorded.

PASSAGE PROBABILITY

6.4% Unlikely

Why this number

Stage base In Committee — base rate 34%, measured from NE's completed sessions
Momentum -5 27/100 from the pace of recorded action
Time since last action -22 201 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.